Association of a transcription factor 21 gene polymorphism with hypertension

  • Authors:
    • Tetsuo Fujimaki
    • Mitsutoshi Oguri
    • Hideki Horibe
    • Kimihiko Kato
    • Reiko Matsuoka
    • Shintaro Abe
    • Fumitaka Tokoro
    • Masazumi Arai
    • Toshiyuki Noda
    • Sachiro Watanabe
    • Yoshiji Yamada
  • View Affiliations

  • Published online on: October 13, 2014     https://doi.org/10.3892/br.2014.371
  • Pages: 118-122
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Various loci and genes that confer susceptibility to coronary artery disease (CAD) have been identified mainly in Caucasian populations by genome‑wide association studies (GWASs). As hypertension is a major risk factor for CAD, certain polymorphisms may contribute to the genetic susceptibility to CAD through affecting the predisposition to hypertension. The aim of the present study was to examine a possible association of hypertension with 29 single‑nucleotide polymorphisms (SNPs) previously identified by meta‑analyses of GWASs as susceptibility loci for CAD. Study subjects comprised of 5,460 individuals (3,348 subjects with hypertension and 2,112 controls). The genotypes of SNPs were determined by the multiplex bead‑based Luminex assay. The χ2 test revealed that genotype distributions and allele frequencies for rs12190287 of the transcription factor 21 gene (TCF21) and rs1122608 of the SWI/SNF‑related, matrix‑associated, actin‑dependent regulator of chromatin, subfamily a, member 4 gene (SMARCA4) were significantly (P<0.05) associated with hypertension. Allele frequencies for rs9369640 of the phosphatase and actin regulator 1 gene (PHACTR1) and genotype distributions for rs599839 of the proline/serine‑rich coiled‑coil 1 gene (PSRC1) were also significantly associated with hypertension. Multivariable logistic regression analysis with adjustment for age, gender, body mass index and smoking status revealed that rs12190287 of TCF21 (P=0.0014; recessive model; odds ratio, 1.21) was significantly associated with hypertension, and the C allele represented a risk factor for this condition. Similar analyses revealed that rs1122608 of SMARCA4 (P=0.0305; dominant model; odds ratio, 0.86), rs9369640 of PHACTR1 (P=0.0119; dominant model; odds ratio, 0.82) and rs599839 of PSRC1 (P=0.0248; dominant model; odds ratio, 0.84) were also related to hypertension, with the minor T, C and G alleles, respectively, being protective against this condition. Thus, the present results indicate that rs12190287 (G→C) of TCF21 is a susceptibility locus for hypertension.
View References

Related Articles

Journal Cover

January-February 2015
Volume 3 Issue 1

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Fujimaki T, Oguri M, Horibe H, Kato K, Matsuoka R, Abe S, Tokoro F, Arai M, Noda T, Watanabe S, Watanabe S, et al: Association of a transcription factor 21 gene polymorphism with hypertension. Biomed Rep 3: 118-122, 2015
APA
Fujimaki, T., Oguri, M., Horibe, H., Kato, K., Matsuoka, R., Abe, S. ... Yamada, Y. (2015). Association of a transcription factor 21 gene polymorphism with hypertension. Biomedical Reports, 3, 118-122. https://doi.org/10.3892/br.2014.371
MLA
Fujimaki, T., Oguri, M., Horibe, H., Kato, K., Matsuoka, R., Abe, S., Tokoro, F., Arai, M., Noda, T., Watanabe, S., Yamada, Y."Association of a transcription factor 21 gene polymorphism with hypertension". Biomedical Reports 3.1 (2015): 118-122.
Chicago
Fujimaki, T., Oguri, M., Horibe, H., Kato, K., Matsuoka, R., Abe, S., Tokoro, F., Arai, M., Noda, T., Watanabe, S., Yamada, Y."Association of a transcription factor 21 gene polymorphism with hypertension". Biomedical Reports 3, no. 1 (2015): 118-122. https://doi.org/10.3892/br.2014.371